Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
TAGITININ C
ID: ALA463060
Max Phase: Preclinical
Molecular Formula: C19H24O6
Molecular Weight: 348.40
Molecule Type: Small molecule
Associated Items:
ID: ALA463060
Max Phase: Preclinical
Molecular Formula: C19H24O6
Molecular Weight: 348.40
Molecule Type: Small molecule
Associated Items:
Synonyms (1): tagitinin C
Synonyms from Alternative Forms(1):
Canonical SMILES: C=C1C(=O)O[C@@H]2/C=C(/C)C(=O)/C=C/[C@](C)(O)C[C@@H](OC(=O)C(C)C)[C@@H]12
Standard InChI: InChI=1S/C19H24O6/c1-10(2)17(21)25-15-9-19(5,23)7-6-13(20)11(3)8-14-16(15)12(4)18(22)24-14/h6-8,10,14-16,23H,4,9H2,1-3,5H3/b7-6+,11-8-/t14-,15-,16+,19+/m1/s1
Standard InChI Key: DUQSSEQKLJQACA-FESGBCJUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 348.40 | Molecular Weight (Monoisotopic): 348.1573 | AlogP: 1.88 | #Rotatable Bonds: 2 |
Polar Surface Area: 89.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.58 | CX LogD: 2.58 |
Aromatic Rings: 0 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: 3.05 |
1. Gu JQ, Gills JJ, Park EJ, Mata-Greenwood E, Hawthorne ME, Axelrod F, Chavez PI, Fong HH, Mehta RG, Pezzuto JM, Kinghorn AD.. (2002) Sesquiterpenoids from Tithonia diversifolia with potential cancer chemopreventive activity., 65 (4): [PMID:11975495] [10.1021/np010545m] |
2. Kaur K, Jain M, Kaur T, Jain R.. (2009) Antimalarials from nature., 17 (9): [PMID:19299148] [10.1016/j.bmc.2009.02.050] |
3. Lin H. (2013) Identification of liver X receptor and farnesoid X receptor dual agonists from Tithonia diversifolia, 22 (7): [10.1007/s00044-012-0359-5] |
4. Schomburg C, Schuehly W, Da Costa FB, Klempnauer KH, Schmidt TJ.. (2013) Natural sesquiterpene lactones as inhibitors of Myb-dependent gene expression: structure-activity relationships., 63 [PMID:23501116] [10.1016/j.ejmech.2013.02.018] |
5. Chibli LA, Schmidt TJ, Nonato MC, Calil FA, Da Costa FB.. (2018) Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase., 157 [PMID:30145372] [10.1016/j.ejmech.2018.08.033] |
Source(1):